Monthly Archives

January 2026

Jan 12
Love0

Mastering Biologic Access in Dermatology: ODAC Preview

By ODAC Sessions

biologic access

Biologics are effective, but getting access can be a challenge. For smoother starts and fewer insurance roadblocks, attend this 30-minute ODAC CME workshop, “Mastering Biologic Access in Dermatology: What Your Biologics Coordinator Wants You to Know,” on Saturday, January 17, from 5:15-5:45 p.m.

Heather Sawrey, biologics coordinator for the GWU Department of Dermatology, brings 17 years of real-world experience helping patients access biologic therapies. She’ll cover best practices for prior authorizations, patient education, pharma support programs, and how clinical teams can work together to reduce delays. Practical, actionable, and time-efficient — perfect for dermatologists, nurses, and clinic staff. (Aren’t yet registered for ODAC? Register today!)

Jan 09
Love0

Dermoscopy Beyond the Basics: ODAC Preview

By ODAC Sessions

dermoscopy

Ready to decode the toughest dermoscopic cases?

Join Jennifer Stein, MD, PhD, FAAD, for “Dermoscopy Beyond the Basics: Identifying Challenging and Atypical Lesions” on Sunday, January 18, from 3:45–4:30 p.m. at ODAC 2026.

This focused CME workshop will highlight real-world, high-yield approaches to recognizing atypical presentations and improving diagnostic confidence. Perfect for dermatologists and trainees who want practical, clinic-ready strategies. You won’t want to miss it!

Jan 07
Love0

GLP-1 Panel: ODAC Preview

By ODAC Sessions

GLP-1 agonists

Curious how GLP‑1 agonists fit into holistic dermatology care? Don’t miss this rapid-fire, 25‑minute panel in the Opening General Session at ODAC 2026 (Jan 16):  

“GLP‑1 Agonists in Cutaneous Medicine: Rapid‑Fire Insights on Comorbidities, Safety, and Aesthetic Considerations”  

Moderator: Adam Friedman, MD, FAAD  

Panelists: Jennifer Soung, MD, FAAD; Steven Daveluy, MD, FAAD; Sarah Jackson, MD, FAAD

What to expect:

– Focused review of metabolic and inflammatory comorbidities in psoriasis and HS  

– Practical evidence and tips for integrating GLP‑1 therapy to address cardiometabolic risk  

– Discussion of potential aesthetic consequences (hair changes, skin laxity) and safety monitoring  

– Multidisciplinary strategies you can use in clinic

This concise, discussion‑driven session is ideal for dermatologists, trainees, and multidisciplinary colleagues wanting actionable, real‑world guidance. See you there!

(Are you just now thinking about ODAC? Don’t miss out: Register today!)

Jan 02
Love0

JDD Video Abstract with ODAC Faculty Dr. Hilary Baldwin

By Uncategorized

acneceuticals

ODAC faculty are not only experts in dermatology – many are involved hands-on with the latest dermatologic research.

Case in point: Dr. Hilary Baldwin. A prolific researcher, Dr. Baldwin is a sought-after speaker on a variety of dermatology topics. At ODAC 2026, Dr. Baldwin will share approaches for treating keloids, provide an acne update for 2026, and address the role of cosmeceuticals in barrier repair.

If you’re looking for a sneak peak, check out Dr. Baldwin’s JDD Video Abstract about a recent study in which she was the lead author, “Real-World Clinical Case Series Utilizing Acneceuticals as Monotherapy, Adjunctive, or Maintenance Therapy for Acne Vulgaris.”

Watch as Dr. Baldwin gives the background on the need for and classification of acneceuticals. Find out the real-world data on the effectiveness of acneceuticals in the treatment of acne vulgaris, both as monotherapy and in conjunction with prescription therapies. Learn from Dr. Baldwin on how acneceuticals can help with patient engagement in their treatment. Plus find out her takeaways from the study and how dermatologists may best recommend acneceuticals for their acne patients.

Be sure to register for ODAC to learn from Dr. Baldwin in-person.

Close Menu